+ All Categories
Home > Documents > Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv,§ורות-חיים...1 Turbv unav s....

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv,§ורות-חיים...1 Turbv unav s....

Date post: 22-Aug-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend

Click here to load reader

Transcript
  • 1

    Turbv unav s.

    CURRICULUM VITAE

    Name: DROR DICKER Identity No: 5769019-0

    Faculty/Dept: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv,

    Israel

    Hospital/Dept: Department of Internal Medicine D' and Obesity Clinic

    Rabin Medical Center, Golda–Hasharon Campus, Petah

    Tikva, Israel

    TEL: 03-9372426/586

    FAX: 03-9372427

    Mobile: 050-4065955

    Email: [email protected]

    Home Address: Kadia Molodovski St. 17 Petah - Tikva

    Phone No. 972-77-5332014

    Date & Place of birth: 2.5.62 Israel

    Zahal (Israeli Military Service): 1980 - 1983

    Marital Status: Married

    No. of Children: 3

  • 2

    A. EDUCATION

    1983-1990 Medicine

    Rappaport Faculty of Medicine, Technion-Israel Institute of Technology,

    Haifa, Israel

    MD Date awarded: 1992

    Title of Doctoral Dissertation: Superoxide Anion Production by Peripheral Blood Neutrophils

    From Patients With Myocardial Infarction.

    Names of Supervisors: M Djeldeti MD.

    P. Fishman Ph.D.

    Specialization Certificate: Internal Medicine Date awarded: 1995

    License number: 22786

    B. FURTHER STUDIES

    1991-1994 Continuing Medical Education - Internal Medicine

    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    1993-1994 Advance Post-Graduate Course on Diabetes.

    Israel Diabetic Association

    2001 Continuing Medical Education – Obesity Treatment.

    University of LAVAL Qubec

    2002- 2002 Continuing Medical Education - Sport Medicine.

    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    2009 Bariatric Multidisciplinary Team Training , St Gallen, Switzerland

  • 3

    C. ACADEMIC & PROFESSIOMAL ACTIVITIES & ACHIEVEMENTS

    C1. ACADEMIC EXPERIENCE

    1995 - Present Instructor, Internal Medicine

    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    2007 GCP – IHC course

    Rabin Medical Center, Petah Tikva, Israel

    CLINICAL RESAERCH

    1992-1996 BIP STUDY – Bezafibrat in ACS patient for CVD prevention

    2003 DIRECT STUDY- Atacand in DM Patients for nephropathy &

    Neuropathy prevention

    2003-2004 PARC-ALLA STUDY – IMT measuring

    2007 RIMON -Rimonabant in IFG patients for DM prevention

    2007 DIRECT STUDY

    2008 dal-OUTCOMES STUDY- Cholesterol lowering in CVD patients

    2009 ENGAGE STUDY

    2010 LEADER STUDY – Liraglitide (GLP1) safety in CVD patients

    2012 GOAL STUDY – Insulin Glariginr – prescription habits

    2014 ESH-SHOT STUDY – Blood pressure targets after ischemic stroke.

    2014 ERTUGLIFLUSIN in Diabetes Mellitus

    2016 Odyssey DM

    2015 NN 9536-41 Semaglutide in Obesity

  • 4

    C2. PROFESSIONAL EXPERIENCE

    1990 Rotating,

    Rabin Medical Center, Golda–Hasharon Campus, Petah Tikva, Israel

    1991-1995 Resident, Internal Medicine C'

    Rabin Medical Center, Golda–Hasharon Campus, Petah Tikva, Israel

    1995-1997 Senior resident, Internal Medicine C'

    Rabin Medical Center, Golda–Hasharon Campus, Petah Tikva, Israel

    1998-1999 Attending Physician, Internal Medicine C'

    Rabin Medical Center, Golda–Hasharon Campus, Petah Tikva, Israel

    1999-2001 Deputy Director, Internal Medicine D'

    Rabin Medical Center, Golda–Hasharon Campus, Petah Tikva, Israel

    2001- 2005 Acting Director, Internal Medicine D'

    Rabin Medical Center, Golda–Hasharon Campus, Petah Tikva, Israel

    2005- Present Director, Internal Medicine D' & Obesity Clinic

    Rabin Medical Center, Golda–Hasharon Campus, Petah Tikva, Israel

  • 5

    APPOINTMENTS

    1999 - 2009 Chief editor of the Medical internet site - "e-med"

    1999 – 2004 Moderator of the weekly hospital staff meeting.

    2001 - 2005 Secretary of the academic board - the Israeli association of internal

    medicine

    2003 – 2015 Secretary of the Israeli forum for cardiovascular disease prevention

    2003 - Present Board member of the Israeli association for the study of obesity.

    2004 - Present Chairman of internship committee – Hasharon Hospital.

    2005 – Present Scope (Specialist Certification of Obesity Professionals in Europe),

    National Fellow.

    2005 - 2010 Secretary of the Israeli association of internal medicine.

    2010 - 2015 President of the Israeli association of internal medicine.

    2013 – Present Fellow (Hon) American College of Physician

    2013 – Present Fellow (Hon) European Federation Of Internal Medicine

    2016 - Present President of the Israeli Association for the Study of obesity

    2017 - Present Co-Chair, Obesity Management Task Force – European Association for

    the Study of obesity

  • 6

    C3. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS

    Date

    Country Subject / Meeting Role

    2003 Tel-Aviv, Israel The 50th

    Annual Conference Of the

    Israeli Heart Society.

    Speaker

    2008 Barcelona, Spain CODHy (The 2nd

    )) Controversies to

    Consensus in Diabetes, Obesity and

    Hypertension

    Faculty

    2008 Thessaloniki,

    Greece

    Macedonian Congress on Nutrition and

    Diabetes

    Speaker

    2009 Nice, France 3rd

    International Congress on Prediabetes International

    Advisory Board,

    Faculty

    2010 Prague, Czech

    Republic.

    CODHy (The 3nd

    )) Controversies to

    Consensus in Diabetes, Obesity and

    Hypertension

    Speaker,

    Scientific Committee

    and Faculty

    2011 Saas-Fee,

    Switzerland

    European school of internal Medicine Speaker

    2011 Barcelona, Spain. 4rd

    International Congress on Prediabetes International

    Advisory Board,

    Faculty

    2011 Shanghai, China

    CODHy (The 1nd

    Asia Pacific Congress)

    Controversies to Consensus in Diabetes,

    Obesity and Hypertension

    Speaker, Faculty

    2011 Istanbul, Turkey 18th

    European Congress of Obesity. Speaker

    2011 Tel Aviv, Israel 10th

    Israeli Nutritional Week Scientific

    Committee, Faculty

    2012 Madrid, Spain. 11th

    congress of European Federation of

    Internal Medicine.

    Speaker, Faculty

    2013 Liverpool,

    England.

    20th

    European Congress of Obesity. Speaker.

    2006 Berlin, Germany. CODHy (The 1nd

    )) Controversies to

    Consensus in Diabetes, Obesity and

    Hypertension

    Speaker, Faculty

    2005-2015 Tel Aviv, Israel Annual Meetings: Internal Medicine

    Association Congress

    Scientific

    Committee.

    2008-2014 Tel- Aviv. Israel. Cardiometabolic Congress. Chairman, Speaker.

  • 7

    2014 Moscow. Russia Annual Meetings: Internal Medicine

    Association

    Speaker

    2015 Prague. Czech

    Republic.

    21th

    European Congress of Obesity. Speaker

    2015 Gothenburg

    Sweden

    22th European Congress of Obesity. Speaker

    2017 Porto Portugal 23th European Congress of Obesity Speaker

    2017 Milano Italy Annual Meetings: Internal Medicine

    Association

    Speaker

    C4. MEMBERSHIP IN PROFESSIONAL SOCIETIES

    Years (period) Name of Organization

    1993 - 1997 International Society for Heart Research, Israel

    1993 - present Israeli Society of Internal Medicine

    1998 - present Israeli Society of Hypertension

    2003 - present Israeli Society of Obesity

    2004 - present European Association For the Study of Obesity

    2004 - 2005 North American Association for the Study of Obesity

    D. DOCTORAL STUDENTS MENTORED BY CANDIDATE

    Years (period) Name of

    Student

    Subject Academic

    Institute

    Ph.D/ M.D In

    collaboration

    with

    E. M.A./M.SC. STUDENTS

    Years (period) Name of Student Subject Academic

    Institute

    In collaboration

    with

  • 8

    F. GRANTS

    Years

    Investigator

    (Principal/,other)

    Granted by

    Institute/Company

    Total Amount

    2015 Principal Investigator Clalit Health Service 48,000 IS

    2016 Principal Investigator BI company 120,000

    G. AWARDS

    1992 Prize for MD Thesis

    Rappaport Faculty of Medicine, Technion-Israel Institute of Technology,

    Haifa, Israel

    1997 Prize for Excellence in Teaching

    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    1998 Prize for Excellence in Tutoring

    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    1998 Grant, R.M.C. Research committee

    2003 Excellence at work, R.M.C Manager

    2014 Prize for Excellence in Tutoring CME of Internal Medicine

    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • 9

    SCIENTIFIC PUBLICATIONS

    B.1. ORIGINAL ARTICLES

    B.1. Articles Published

    B1-1 Fishman P, Falach-Vaknin E, Sredni B, Meroni PL, Tincani A, Dicker D, Shoenfeld

    Y.

    Aspirin-interleukin-3 interrelationships in patients with anti-phospholipid syndrome.

    Am J Reprod Immunol. 1996;35:80-84.

    (REPRODUCTIVE BIOLOGY 11/29 Q2, IF 2.745, No of Citations 34)

    B1-2 Melamed Y, Sirota P, Dicker D (Dicker DR), Fishman P.

    Superoxide anion production by neutrophils derived from peripheral blood of

    schizophrenic patients.

    Psychiatry Res. 1998;77:29-34.

    (PSYCHIATRY 61/142 Q2, IF 2.223, No of Citations 14)

    B1-3 Komlos L, Zahavi Z, Dicker D, Luria D, Salman H, Zahavi I.

    In vitro modulation of activation antigens on human lymphocytes by beta-estradiol.

    Am J Reprod Immunol. 1998;40:418-423.

    (REPRODUCTIVE BIOLOGY 11/29 Q2, IF 2.745, No of Citations 6)

    B1-4 Yosefy C, Ginsberg GM, Dicker D, Viskoper JR, Tulchinsky TH, Leibovitz E,

    Gavish D; IBPC Investigators.

    Risk factor profile and achievement of treatment goals among hypertensive patients

    from the Israeli Blood Pressure Control (IBPC) program--initial cost utility analysis.

    Blood Press. 2003;12:225-231.

    (PERIPHERAL VASCULAR DISEASE 41/65 Q3, IF 2.107, No of Citations 5)

  • 10

    B.1. Articles Published

    B1-5 Viskoper R, Shapira I, Priluck R, Mindlin R, Chornia L, Laszt A, Dicker D, Gavish

    B, Alter A.

    Nonpharmacologic treatment of resistant hypertensives by device-guided slow

    breathing exercises.

    Am J Hypertens. 2003;16:484-487.

    (PERIPHERAL VASCULAR DISEASE 23/65 Q2, IF 3.046, No of Citations 44)

    B1-6 Yosefy C, Dicker D, Viskoper JR, Tulchinsky TH, Ginsberg GM, Leibovitz E,

    Gavish D.

    The Ashkelon Hypertension Detection and Control Program (AHDC Program): a

    community approach to reducing cardiovascular mortality.

    Prev Med. 2003;37(6 Pt 1):571-576.

    (MEDICINE, GENERAL & INTERNAL 25/155 Q1, IF 3.483, No of Citations 12)

    B1-7 Leibovitz E, Gavish D, Dicker D, Viskoper RJ, Yosefi C.

    Risk factor profile and achievement of treatment goals among hypertensive patients

    in general practice in Israel: baseline results from the Israeli Blood Pressure Control

    program.

    Isr Med Assoc J. 2003;5:697-701.

    (MEDICINE, GENERAL & INTERNAL 78/103 Q4, IF 0.51, No of Citations 4)

    B1-8 Ram E, Vishne T, Dicker D, Gal-Ad I, Maayan R, Lerner I, Dreznik Z, Seror D,

    Vardi P, Weizman A.

    Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and

    DHEA-S levels.

    Obes Surg. 2005;15:1118-1123.

    (SURGERY 18/200 Q1, IF 3.89, No of Citations 26)

  • 11

    B.1. Articles Published

    B1-9 Dicker D, Maya I, Vasilevsky V, Gofman M, Markowitz D, Beilin V, Sarid M,

    Yosefy C.

    Blood pressure variability in acute ischemic stroke depends on hemispheric stroke

    location.

    Blood Press. 2006;15:151-156.

    (PERIPHERAL VASCULAR DISEASE 41/65 Q3, IF 2.107, No of Citations 6)

    B1-10 Dicker D, Vishne T, Maayan R, Weizman A, Vardi P, Dreznik Z, Seror D, Ram E.

    Impact of gastric banding on plasma adiponectin levels.

    Obes Surg. 2006;16:1057-1061.

    (SURGERY 18/200 Q1, IF 3.89, No of Citations 14)

    B1-11 Bachar GN, Atar E, Fuchs S, Dicker D (Dror D), Kornowski R.

    Prevalence and clinical predictors of atherosclerotic coronary artery disease in

    asymptomatic patients undergoing coronary multidetector computed tomography.

    Coron Artery Dis. 2007;18:353-360.

    (CARDIAC & CARDIOVASCULAR SYSTEMS 85/128 Q3, IF 1.705, No of

    Citations 26)

    B1-12 Dicker D, Belnic Y, Goldsmith R, Kaluski DN.

    Relationship between dietary calcium intake, body mass index, and waist

    circumference in MABAT--the Israeli National Health and Nutrition Study.

    Isr Med Assoc J. 2008;10:512-515.

    (MEDICINE, GENERAL & INTERNAL 114/155 Q3, IF 0.817, No of Citations 23)

    B1-13 Dicker D, Herskovitz P, Katz M, Atar E, Bachar GN.

    Computed tomography study of the effect of orlistat on visceral adipose tissue

    volume in obese subjects.

    Isr Med Assoc J. 2010;12:199-202.

    (MEDICINE, GENERAL & INTERNAL 114/155 Q3, IF 0.817, No of Citations 6)

  • 12

    B.1. Articles Published

    B1-14 Bachar GN*, Dicker D*, Kornowski R, Atar E.

    *Equal Contribution

    Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic

    subjects.

    Am J Cardiol. 2012;110:534-538.

    (CARDIAC & CARDIOVASCULAR SYSTEMS 49/128 Q2, IF 3.171,

    No of Citations 56)

    B1-15 Dicker D, Salook MA, Marcoviciu D, Djaldetti M, Bessler H.

    Role of peripheral blood mononuclear cells in the predisposition of obese individuals

    to inflammation and infection.

    Obes Facts. 2013;6:146-151.

    (NUTRITION & DIETETI 34/83 Q2, IF 3.108, No of Citations 11)

    B1-16 Schneer S, Bachar GN, Atar E, Koronowski R, Dicker D.

    Evaluation of framingham and systematic coronary risk evaluation scores by

    coronary computed tomographic angiography in asymptomatic adults.

    Am J Cardiol. 2013;111:700-704.

    (CARDIAC & CARDIOVASCULAR SYSTEMS 49/128 Q2, IF 3.171,

    No of Citations 7)

    B1-17 Dicker D, Atar E, Kornowski R, Bachar GN.

    Increased epicardial adipose tissue thickness as a predictor for hypertension: a cross-

    sectional observational study.

    J Clin Hypertens (Greenwich). 2013;15:893-898.

    (PERIPHERAL VASCULAR DISEASE 33/65 Q3, IF 2.629, No of Citations 11)

  • 13

    B.1. Articles Published

    B1-18 Elis A, Pereg D, Dicker D, Gevrielov-Yusim N, Goldenberg I, Matetzky S, Kopel E,

    Klempfner R.

    Temporal trends in the use of high-dose potent statins following acute coronary

    syndrome in Israel.

    Cardiology. 2014;128:266-272.

    (CARDIAC & CARDIOVASCULAR SYSTEMS 85/128 Q3, IF 1.714,

    No of Citations 1)

    B1-19 Kramer MH, Bauer W, Dicker D, Durusu-Tanriover M, Ferreira F, Rigby SP, Roux

    X, Schumm-Draeger PM, Weidanz F, van Hulsteijn JH;

    Working Group on Professional Issues; European Federation of Internal medicine.

    The changing face of internal medicine: patient centred care.

    Eur J Intern Med. 2014;25:125-127.

    (MEDICINE, GENERAL & INTERNAL 27/155 Q1, IF 3.282, No of Citations 11)

    B1-20 Bergman M*, Dicker D*, Blumberger N, Brener ZZ, Ori Y, Salman H.

    *Equal Contribution

    Prolonged international normalized ratio during the first year of warfarin treatment.

    Am J Med Sci. 2014;348:71-74.

    (MEDICINE, GENERAL & INTERNAL 68/155 Q2, IF 1.773, No of Citations 1)

    B1-21 Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo

    G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR,

    Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S,

    Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F,

    Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I,

    Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis

    AJ, Stylianou P, Erdine S, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford

    G.

  • 14

    Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and

    cognitive decline in the hypertensive patient: design of the European Society of

    Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal

    Treatment randomized trial.

    J Hypertens. 2014;32:1888-1897.

    (PERIPHERAL VASCULAR DISEASE 11/65 Q1, IF 4.099, No of Citations 35)

    B1-22 Koifman E, Grossman E, Elis A, Dicker D, Koifman B, Mosseri M, Kuperstein R,

    Goldenberg I, Kamerman T, Levine-Tiefenbrun N, Klempfner R.

    Multidisciplinary rehabilitation program in recently hospitalized patients with heart

    failure and preserved ejection fraction: Rationale and design of a randomized

    controlled trial.

    Am Heart J. 2014;168: 830-837.e1.

    (CARDIAC & CARDIOVASCULAR SYSTEMS 39/128 Q2, IF 4.171,

    No of Citations 9)

    B1-23 Segal-Lieberman G, Segal P, Dicker D .

    Revisiting the Role of BMI in the Guidelines for Bariatric Surgery

    Diabetes Care. 2016 Aug;39 Suppl 2:S268-73 .

    (ENDOCRINOLOGY & METABOLISM 5/142 Q1, IF 13.397, No of Citations 1)

    B1-24 Dicker D, Yahalom R, Comaneshter DS, Vinker S

    Long-Term Outcomes of Three Types of Bariatric Surgery on Obesity and Type 2

    Diabetes Control and Remission.

    Obes Surg. 2016 Aug;26(8):1814-20.

    (SURGERY 18/200 Q1, IF 3.89, No of Citations 15)

    B1-25 Dicker D, Feldman BS, Leventer-Roberts M , Benis A

    Obesity or smoking: Which factor contributes more to the incidence of myocardial

    infarction?

    Eur J Intern Med. 2016 Jul;32:43-6. Epub 2016 Apr 14.

    (MEDICINE, GENERAL & INTERNAL 27/155 Q1, IF 3.282, No of Citations 4)

  • 15

    B.1. Articles Published

    B1-26 Akirov A., Dicker D., Shochat T, Shimon I.

    Mortality risk in admitted patients with diabetes mellitus according to treatment.

    J Diabetes Complications. 2016 Aug;30(6):1025-31. Epub 2016 Apr 16.

    (ENDOCRINOLOGY & METABOLISM 84/142 Q3, IF 2.792, No of Citations 2)

    B1-27 Meir AY, Tene L, Cohen N, Shelef I, Schwarzfuchs D, Gepner Y, Zelicha H, Rein M,

    Bril N, Serfaty D, Kenigsbuch S, Chassidim Y, Sarusy B, Dicker D, Thiery J,

    Ceglarek U, Stumvoll M, Blüher M, Stampfer MJ, Rudich A, Shai I.

    Intrahepatic fat, abdominal adipose tissues, and metabolic state: magnetic resonance

    imaging study.

    Diabetes Metab Res Rev. 2017 Jul;33(5). Epub 2017 Mar 14.

    (ENDOCRINOLOGY & METABOLISM 39/142 Q2, IF 3.904, No of Citations 0)

    B1-28 Dubnov-Raz G, Steinacker JM, Marcus Y, Dipla K, Dicker D, Hoffman JR, Shimon I,

    Greenman Y, Tripto-Shkolnik L, Hirsch D, Buch A, Arieli M, Constantini NW.

    Exercise is Medicine Israel 5th Annual Conference - Endocrine Aspects Tel Aviv,

    Israel, May 10th, 2017

    Pediatr Endocrinol Rev. 2017 Sep;15(1):57-59.

    (ENDOCRINOLOGY & METABOLISM 130/142 Q4, IF 1.086, No of Citations 0)

    B1-29 Aron-Wisnewsky J, Sokolovska N, Liu YJ, Comaneshter DS, Vinker S, Pecht T, Poitou

    C, Oppert JM, Bouillot JL, Genser L, Dicker D, Zucker JD, Rudich A, Clement K.

    The advanced-DiaRem score improves prediction of diabetes remission 1 year

    post-Roux-en-Y gastric bypass.

    Diabetologia 2017 Oct;60(10):1892-1902. Epub 2017 Jul 21.

    (ENDOCRINOLOGY & METABOLISM 16/142 Q1, IF 6.023, No of Citations 3)

  • 16

    B.1. Articles Published

    B1-30 Tsaban G, Wolak A, Avni-Hassid H, Gepner Y, Shelef I, Henkin Y, Schwarzfuchs D,

    Cohen N, Bril N, Rein M, Serfaty D, Kenigsbuch S, Tene L, Zelicha H, Yaskolka-Meir

    A, Komy O, Bilitzky A, Chassidim Y, Ceglarek U, Stumvoll M, Bluher M, Thiery J,

    Dicker D, Rudich A, Stampfer MJ, Shai, I.

    Dynamics of intrapericardial and extrapericardial fat tissues during long-term,

    dietary-induced, moderate weight loss.

    Am J Clin Nutr. 2017 Oct;106(4):984-995. Epub 2017 Aug 16.

    (NUTRITION & DIETETICS 4/83 Q1, IF 6.549, No of Citations 1)

    B1-31 Akirov A, Shochat T, Masri-Iraqi H, Dicker D, Diker-Cohen T, Shimon I.

    Body mass index and mortality in patients with and without diabetes mellitus.

    Diabetes Metab Res Rev. 2017 Dec 27.

    (ENDOCRINOLOGY & METABOLISM 39/142 Q2, IF 3.904, No of Citations 0)

    B1-32 Reges O, Greenland P, Dicker D, Leibowitz M, Hoshen M, Gofer I,

    Rasmussen-Torvik, LJ, Balicer RD.

    Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric

    Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With

    All-Cause Mortality.

    JAMA. 2018 Jan 16;319(3):279-290.

    (MEDICINE, GENERAL & INTERNAL 3/155 Q1, IF 47.661, No of Citations 13)

  • 17

    articles 32of out 11 The no. of articles marked Q1

    בתחומם, (Q1) ברביע העליון כיום תונים המדורגיםימאמרים שפורסמו בע

    מאז המינוי האחרון

    מס' מאמר

    )כפי

    שמופיע

    (CV-ב

    Q-ו IF שנת פרסום שם העיתון בשנת פרסום

    IF ו-Q כיום

    B1-6 icinedMe entivePrev 2003 Q1,

    IF 1.889

    Q1,

    IF 3.483

    B1- 8 erySurg yitObes 2005 Q1,

    IF 3.759

    Q1,

    IF 3.895

    B1-10 Surgery ityObes 2006 Q1,

    IF 3.723

    Q1,

    IF 3.895

    B1-19 ournal ofJ opeanEur

    icineMed alIntern

    2014 Q1,

    IF 2.891

    Q1,

    IF 3.282

    B1-21 ournal ofJ

    ionHypertens

    2014 Q1,

    IF 4.720

    Q1,

    IF 4.092

    B1-23 eDiabetes Car 2016 Q1

    IF 11.857

    Q1,

    IF 13.397

    B1-24 Surgery ityObes 2016 Q1,

    IF 3.947

    Q1,

    IF 3.895

    B1-25 ournal ofJ opeanEur

    icineMed alIntern

    2016 Q1,

    IF 2.960

    Q1,

    IF 3.282

    B1-29 Diabetologia 2017 Q1,

    IF 6.023

    Q1,

    IF 6.023

    B1-30 ournal ofJ ericanAm

    itionNutr icalClin

    2017 Q1,

    IF 6.549

    Q1,

    IF 6.549

    B1-32

    JAMA 2018 Q1,

    IF 47.661

    Q1,

    IF 47.661

  • 18

    B.2. CASE REPORTS

    B.2. Case Reports Published

    B2-1 Korzets A, Dicker D, Chaimoff C, Zevin D.

    Life-threatening hyperphosphatemia and hypocalcemic tetany following the use of

    fleet enemas.

    J Am Geriatr Soc. 1992;40:620-621.

    (GERONTOLOGY 2/36 Q1, IF 4.155, No of Citations 41)

    B2-2 Zeidman A, Dicker D, Mittelman M.

    Interferon-induced vasospasm in chronic myeloid leukaemia.

    Acta Haematol. 1998;100:94-96.

    (HEMATOLOGY 61/71 Q4, IF 1.307, No of Citations 13)

    B2-3 Salman H, Herskovitz PI, Brandis S, Bergman M, Dicker D, Zahavi I.

    Huge coronary artery aneurysms presenting as mediastinal masses.

    Isr Med Assoc J. 1999;1:53-54.

    (MEDICINE, GENERAL & INTERNAL 78/103 Q4, IF 0.51, No of Citations 0)

    B2-4 Grinblat J, Weiss A, Grosman B, Dicker D, Beloosesky Y.

    Diarrhea in elderly patients due to Clostridium difficile associated with Salmonella

    and Shigella infection.

    Arch Gerontol Geriatr. 2004;39:277-282.

    (GERIATRICS & GERONTOLOGY 32/53 Q3, IF 2.241, No of Citations 3)

    B2-5 Korzets A, Gafter U, Dicker D, Herman M, Ori Y.

    Levofloxacin and rhabdomyolysis in a renal transplant patient.

    Nephrol Dial Transplant. 2006;21:3304-3305.

    (UROLOGY & NEPHROLOGY 10/76 Q1, IF 4.6, No of Citations 7)

  • 19

    B.2. Case Reports Published

    B2-6 Dicker D, Markovitz D, Rothman M, Sendovski U.

    Coma as a presenting sign of Datura stramonium seed tea poisoning.

    Eur J Intern Med. 2007;18:336-338.

    (MEDICINE, GENERAL & INTERNAL 27/154 Q1, IF 3.282, No of Citations 19)

    B.3. REVIEW ARTICLES

    B.3. Review Articles Published

    B3-1 Solun B, Marcoviciu D, Dicker D.

    Does treatment of hypertension decrease the incidence of atrial fibrillation and

    cardioembolic stroke?

    Eur J Intern Med. 2009;20:125-131.

    (MEDICINE, GENERAL & INTERNAL 27/154 Q1, IF 3.282, No of Citations 4)

    B3-2 Dicker D.

    DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors.

    Diabetes Care. 2011;34 Suppl 2:S276-278.

    (ENDOCRINOLOGY & METABOLISM 5/143Q1, IF 13.397, No of Citations 90)

    B3-3 Solun B, Marcoviciu D, Dicker D.

    Dipeptidyl peptidase-4 inhibitors and their effects on the cardiovascular system.

    Curr Cardiol Rep. 2013;15:382.

    (CARDIAC & CARDIOVASCULAR SYSTEMS 74/128 Q3, IF 1.958, No of

    Citations 6)

  • 20

    B.3. Review Articles Published

    B3-4 Nauck M, Azar ST, Blonde L, Dicker D, Domingo MP, Eliaschewitz FG, Nikonova

    E, Roussel R, Sakaguchi K, Sauque-Reyna L, Bailey CJ.

    Relationship between Changes in Postprandial Glucagon, Patient Characteristics, and

    Response to Lixisenatide as Add-on to Oral Antidiabetics.

    DIABETES JUN. 2014; 63: A249-A249 Sup:1

    (ENDOCRINOLOGY & METABOLISM 10/143 Q1, IF 7.723, No of Citations 1)

    B3-5 Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo

    G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR,

    Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S,

    Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F,

    Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I,

    Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis

    AJ, Stylianou P, Erdine S, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford

    G.

    Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of

    strokes and cognitive decline: a review of available trial evidence.

    J Hypertens. 2014 Sep;32:1741-1750.

    (PERIPHERAL VASCULAR DISEASE 11/65 Q1, IF 4.092, No of Citations 22)

    B3-6 Spivak H, Sakran N, Dicker D, Rubin M, Raz I, Shohat T, Blumenfeld O.

    Different effects of bariatric surgical procedures on dyslipidemia: a registry-based

    analysis.

    Surg Obes Relat Dis. 2017 Jul;13(7):1189-1194. Epub 2017 Mar 23

    (SURGERY 17/200 Q1, IF 3.9, No of Citations 1)

  • 21

    C. CHAPTERS IN BOOKS

    C-1 Dicker D

    Diabetes Mellitus Type 2 and Obesity, Diabetes Treatment Instructor.

    National Council of Diabetes 2011,126-134

    D.1.INVITED PAPERS IN SCIENTIFIC MEETINGS

    1. The importance of early effective treatment of Diabetes and its complication. Panel

    Discussion. CODHy (The 1nd

    ) Controversies to Consensus in Diabetes, Obesity and

    Hypertension. Berlin, Germany. 2006.

    2. Normometabolic obesity: myth or reality? Macedonian Congress on Nutrition and Diabetes.

    Thessaloniki, Greece 2008.

    3. The Israeli Blood Pressure Control (IBPC) Program. (Abstract presentation)

    4. Impact of glycaemic control impact on body weight potential to reduce cardiovascular

    risk. CODHy (The 3nd

    )) Controversies to Consensus in Diabetes, Obesity and Hypertension,

    Prague, Czech Republic. 2010.

    5. Metabolic Syndrome, European school of internal Medicine, Saas-Fee, Switzerland, 2011.

    6. The Risk of Hypertension in diabetic patients. CODHy (The 1ndAsia Pacific Congress)

    Controversies to Consensus in Diabetes, Obesity and Hypertension, Shanghai Chaina 2011.

    7. The Fatty Heart. 18th European Congress of Obesity, Istanbul, Turkey, 2011

    8. The Burden of Diabetes and Obesity. 11th congress of European Federation of Internal

    Medicine. Madrid, Spain 2012.

    9. Metabolically healthy obese patient cases. 20th European Congress of Obesity, Liverpool,

    England. 2013.

  • 22

    10. Bariatric Surgery and Diabetes. Annual Meetings: Russian Internal Medicine Association,

    Moscow, Russia 2014.

    11. Bariatric Surgery: Medico-Surgical Session 20th European Congress of Obesity, Prague,

    Czech Republic 2015.

    D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS

    D.3. ABSTRACTS

    1. Dror Dicker, Marina Gofman, Ehud Grossman. Variation in blood pressure measurement as

    dependent on sedentary versus physically active occupation. American J Hypertension. 2003

    May;16(5):208A.(P-467)

    2. Improvement of risk factor management amongst hypertensive patients by educating

    family practitioners . The Israeli Blood Pressure Control Program. (IBPC). Dov Gavish,

    Eyal Lebovitz, Chaim Yosefi, Dror Dicker. American J Hypertension. 2003

    May;16(5):244A.(P-569).

    3. Dicker Dror, Belnic Yulia, Goldsmith Rebecca, Green Manfred, Nitzan-Kaluski Dorit. On the

    relationship between dietary calcium intake, body mass and waist size. International J of Obesity.

    May 2004;28 (S2):S59(P1b-010).

    4. D. Dicker, V. Vasilevski, M.Gofman, D. Markovitz, V.Beillin, M. Sarid. Blood pressure

    variability in acute ischemic stroke: Dependence on stroke location. J of Hypertension. June 2004

    22(S2):S105(P1.304 )

    5. Cost utility analysis of results from the Israeli Blood Pressure Control Program (IBPC). D.

    Gavish, C Yosefi, D Dicker, R.J. Viskoper, E Lebovitz. J of Hypertension. June 2004

    22(S2):S234(P2.292 )

    6. Dicker D, Goldsmith Rebecca, Ben-Dor N. Correlation between generalized and abdominal

    obesity indicators in elderly : The Israeli National Health and Nutrition study in elderly

    population 200506 Mabat-Zahav. Obesity Reviews. July 2010;11 (S1):332(PO.109).

    7. Dicker D, Goldsmith Rebecca, Ben-Dor N. Relationship between dietary calcium intake and

    anthropometric measurement in Mabat-Zahav. Obesity Reviews. July 2010;11 (S1):371(PO.240).

    8. Dicker D, Yahalom R, Comaneshter D, Vinker S. Long term outcomes of three types of bariatric

    surgery on obesity and type 2 diabetes. Obesity Facts. May 2015:8(S1):227(T8:PO.071)

  • 23

    E. ITEMS IN ENCYCLOPEDIAS

    F. BOOKS EDITED

    G. OTHER PUBLICATIONS (Encyclopedias; Reports; Letter to Editors)

    1. Yosefy C, Ginsberg G, Viskoper R, Dicker D, Gavish D.

    Cost-utility analysis of a national project to reduce hypertension in Israel.

    Cost Eff Resour Alloc. 2007;5:16.

    (NO IF)

    2. Dicker D, Djaldetti M, Abo Salook M, Bessler H.

    On the impaired immune function of mononuclear cells in obesity-who is to be

    blamed?

    Int J Immunol. 2014:8:2314-2319.

    (NO IF)

    3. Dicker D, Marcoviciu D, Beylin V, Belnik Y, Solun B.

    The efficacy of a standardized electronic insulin orders in controlling blood glucose

    levels in internal medicine departments.

    J Diabet Metabol.

    (NO IF)

    4. Schneer S, Marcoviciu D, Beilin V, Goffman M, Dicker D.

    Stroke as a manifestation of acute Bartonella henselae endocarditis.

    Harefuah. 2007;146:902-904, 908.

    (NO IF)

    5. Shoenfeld Y, Dicker D, Mittelman M, Bitterman H.

    Internal medicine 2007--where do we stand? To expand or to reduce?

    Harefuah. 2007;146:250-252.

    (NO IF)

  • 24

    G. OTHER PUBLICATIONS

    6. Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V,

    Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X,

    Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S,

    Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F,

    Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I,

    Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis

    AJ, Stylianou P, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G;

    ESH-CHL-SHOT trial investigators.

    Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale

    for further study on blood pressure targets of antihypertensive treatment after stroke.

    J Hypertens. 2016 Mar;34(3):393-6 .

    Editorial Material

    (PERIPHERAL VASCULAR DISEASE 11/65 Q1, IF 4.092, No of Citations 12)

    H. MEMBER OF EDITORIAL BOARD/ REVIEWER (INTERNATIONAL JOURNALS)

    Vice editor Israeli Journal of Medicine December 2007 issue

    Co-editor Medicine Diabetes July-September 2009 issue


Recommended